SCHEMBL25327751

SCHEMBL25327751

COc1cc(Nc2nccc(-c3cc(C(=O)O)n(C)n3)n2)cc(OC)c1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 15/20 0.66
ZAP70 P43403 4/20 0.56
PRKCB P05771 2/20 0.56
PRKD3 O94806 1/20 0.56
PRKCG P05129 1/20 0.56
LCK P06239 1/20 0.56
PRKCA P17252 1/20 0.56
PRKCH P24723 1/20 0.56
PRKCI P41743 1/20 0.56
PRKCE Q02156 1/20 0.56
PRKCQ Q04759 1/20 0.56
PRKCZ Q05513 1/20 0.56
PRKCD Q05655 1/20 0.56
PRKD1 Q15139 1/20 0.56
JAK2 O60674 10/20 0.54
CDK2 P24941 2/20 0.54
EGFR P00533 1/20 0.54
PIK3CA P42336 1/20 0.54
PIK3CB P42338 1/20 0.54
PIK3CG P48736 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25327704 0.90 SYK (0.66) SYKZAP70PRKCBJAK2CDK2
SCHEMBL25327982 0.87 SYK (0.65) SYKZAP70PRKCBJAK2FLT3
SCHEMBL29492413 0.87 SYK (0.65) SYKZAP70PRKCBJAK2FLT3
SCHEMBL25326552 0.87 SYK (0.63) SYKZAP70PRKCBPRKD3PRKCG
SCHEMBL25329089 0.84 SYK (0.72) SYKJAK2FLT3LYN
SCHEMBL25327593 0.83 SYK (0.58) SYKZAP70PRKCBJAK2PIK3CA
SCHEMBL25326813 0.83 SYK (0.64) SYKJAK2FLT3LYN
SCHEMBL25329037 0.83 SYK (0.64) SYKJAK2FLT3LYN
SCHEMBL25328502 0.82 SYK (0.66) SYKZAP70PRKCBPRKD3PRKCG
SCHEMBL25328200 0.82 SYK (0.54) SYKZAP70PRKCBJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240285621-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2024-08-29 US disclosed
EP-4217354-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2023-08-02 EP disclosed
CN-116323595-A Pyrazolyl-pyrimidine derivatives as kinase inhibitors 内尔维亚诺医疗科学公司 2023-06-23 CN disclosed
WO-2022063646-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240285621-A1 PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS SYK, LCK, BTK SYK 1/4885ZAP70 4/4885PRKCB 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.